drugset
drugset / Trial / NCT01002963

A Study To Investigate The Safety And Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers

NCT01002963 ↗

Phase 1 Completed 56 enrolled Pfizer
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to investigate safety and toleration of single oral doses as well as the time course of PF-04418948 concentration in the blood following dosing by oral solution.

Timeline

Start
2009-09
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-04418948 Small molecule 30 mg Oral
Subject PF-04418948 Small molecule 100 mg Oral
Subject PF-04418948 Small molecule 300 mg Oral
Subject PF-04418948 Small molecule 1000 mg Oral
Subject PF-04418948 Small molecule 3000 mg Oral
Subject PF-04418948 Small molecule 4500 mg Oral
Subject PF-04418948 Small molecule 6000 mg Oral

Indications

No indication recorded.